Clinical Trials in Georgia

Showing 17701-17720 of 19,050 trials

Neoadjuvant Chemotherapy + Herceptin in HER2 Positive Stage II-III Breast Cancer Patients

NCT00270894

The purpose of this study is to evaluate the effectiveness and tolerability of the combination of the following medications given every two weeks in HER2 positive breast cancer patients: * trastuzumab (Herceptin) * epirubicin (Ellence) * cyclophosphamide (Cytoxan) * docetaxel (Taxotere)

Breast Neoplasm

Accelerated Community Oncology Research Network30 participantsStarted Nov 2005

Miami, Florida, United States • Augusta, Georgia, United States • Macon, Georgia, United States +4 more locations

COMPLETEDPhase 363 miles

Induction/Simplification With Atazanavir + Ritonavir + Abacavir/Lamivudine Fixed-Dose Combination In HIV-1 Infection

NCT00440947

This study was designed to test the efficacy, safety, tolerability and durability of the antiviral response between atazanavir (ATV) + ritonavir (/r) + abacavir/lamivudine(ABC/3TC) Fixed dose combination (FDC) each administered once daily (QD) for 36 weeks followed by randomization to either a simplification regimen of ATV or continuation of ATV +/r for an additional 48 weeks, each in combination with ABC/3TC in antiretroviral (ART)-naive, HIV-1 infected, HLA-B\*5701 negative subjects. All subjects who complete the 84-week study will be eligible to enter the treatment extension phase and continue for an additional 60 weeks. The purpose of this extension is to obtain longer term treatment data in subjects who have completed the 84-week study.

Infection, Human Immunodeficiency Virus IHIV Infection

ViiV Healthcare515 participantsStarted Mar 2007

Phoenix, Arizona, United States • Long Beach, California, United States • Los Angeles, California, United States +69 more locations

Neoadjuvant Chemotherapy + Herceptin in HER2 Positive Stage II-III Breast Cancer Patients

Induction/Simplification With Atazanavir + Ritonavir + Abacavir/Lamivudine Fixed-Dose Combination In HIV-1 Infection

Find Trials by Condition in Georgia

Study Evaluating Desvenlafaxine Succinate Sustained-Release (DVS SR) In The Treatment Of Peri- And Postmenopausal Women With Major Depressive Disorder (DVS 3364)

Comparative Study of Micafungin (FK463) Versus Placebo as Prophylactic Antifungal Therapy in the ICU

Surgical Outcomes in Pediatric Patients With Coarctation and VSD

Infant Weight Gain With Trisomy 21 and CAVC

Death Following Congenital Heart Surgery

Child With Anomalous Drainage of IVC to Left Atrium

Rare Tumor Case Review

Efficacy and Safety Study of Seroquel SR in the Treatment of Generalised Anxiety Disorder

Prospective Two-Year Study to Assess Miconazole Nitrate Resistance in Neonates and Infants

Effect of Ferrlecit® Versus Oral Iron on Iron Deficient Chronic Kidney Disease (CKD) Patients

CTS-1027 in Interferon-Naive Hepatitis C Patients

Study to Assess Efficacy of Tacrolimus + Methotrexate Versus Placebo + Methotrexate in Treatment of Rheumatoid Arthritis

Pressure Ulcer Prevention: Turning for Ulcer Reduction

A Study of the Pharmacokinetics and Safety of Varespladib in Subjects With Normal or Impaired Renal Function

A Comparison Of Study Drug Blood Levels After One Dose Of GSK189075 In Subjects With Normal And Reduced Kidney Function

Effect of Platelet Concentrate in Treatment of Diabetic Ulcers

Neoadjuvant Imatinib in Dermatofibrosarcoma Protuberans

Use of Cold and Compression Therapy With Total Knee Replacement Patients